Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$0.96 - $1.26 $3,222 - $4,229
3,357 Added 71.55%
8,049 $6,000
Q2 2022

Aug 10, 2022

SELL
$1.16 - $1.88 $6,498 - $10,531
-5,602 Reduced 54.42%
4,692 $5,000
Q1 2022

May 16, 2022

BUY
$1.15 - $2.34 $3,602 - $7,331
3,133 Added 43.75%
10,294 $17,000
Q4 2021

Feb 14, 2022

BUY
$1.48 - $2.92 $6,668 - $13,157
4,506 Added 169.72%
7,161 $16,000
Q3 2021

Nov 15, 2021

BUY
$2.15 - $3.44 $2,171 - $3,474
1,010 Added 61.4%
2,655 $6,000
Q2 2021

Aug 13, 2021

BUY
$2.6 - $3.91 $4,274 - $6,428
1,644 Added 164400.0%
1,645 $5,000
Q1 2021

May 12, 2021

BUY
$3.1 - $5.95 $3 - $5
1 New
1 $0
Q3 2020

Nov 12, 2020

SELL
$23.7 - $51.1 $44,082 - $95,046
-1,860 Closed
0 $0
Q2 2020

Jul 31, 2020

BUY
$7.2 - $24.87 $13,392 - $46,258
1,860 New
1,860 $43,000
Q2 2019

Aug 14, 2019

SELL
$5.43 - $7.19 $5,131 - $6,794
-945 Closed
0 $0
Q1 2019

May 14, 2019

SELL
$4.76 - $5.8 $9,743 - $11,872
-2,047 Reduced 68.42%
945 $5,000
Q4 2018

Feb 14, 2019

SELL
$3.97 - $5.99 $6,193 - $9,344
-1,560 Reduced 34.27%
2,992 $14,000
Q3 2018

Nov 14, 2018

BUY
$5.5 - $6.78 $18,078 - $22,285
3,287 Added 259.84%
4,552 $25,000
Q2 2018

Aug 14, 2018

SELL
$5.55 - $6.93 $4,440 - $5,544
-800 Reduced 38.74%
1,265 $8,000
Q1 2018

May 15, 2018

BUY
$5.43 - $7.49 $11,212 - $15,466
2,065 New
2,065 $11,000

About BiondVax Pharmaceuticals Ltd.


  • Ticker BVXV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,678,800
  • Market Cap $12M
  • Description
  • BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...
More about BVXV
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.